amrinone has been researched along with Acute Disease in 9 studies
Amrinone: A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.
amrinone : A 3,4'-bipyridine substituted at positions 5 and 6 by an amino group and a keto function respectively. A pyridine phosphodiesterase 3 inhibitor, it is a drug that may improve the prognosis in patients with congestive heart failure.
Acute Disease: Disease having a short and relatively severe course.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 55-year-old man developed acute respiratory failure, pulmonary hypertension and left heart failure due to acute myocardial infarction." | 5.30 | Concurrent administration of amrinone with nitric oxide most improves PaO2/FiO2 in acute respiratory and cardiac failure. ( Fujimori, M; Hayashi, M; Yamada, T; Yukioka, H, 1999) |
| " Catecholamine dosage was held constant during the period of the study." | 5.27 | Effect of amrinone in acute severe cardiac failure. ( Frenking, B; Gülker, H; Heuer, H, 1988) |
| "The authors describe the results obtained treating with amrinone for 48 hours 11 patients with acute heart failure." | 3.68 | [Efficacy and safety of amrinone in the treatment of heart insufficiency in intensive care]. ( Agrò, C; Costa, P; Gulotta, G; Papa, G; Piazza, F; Ronga, F; Sansone, A; Sparacia, B, 1992) |
| "A 55-year-old man developed acute respiratory failure, pulmonary hypertension and left heart failure due to acute myocardial infarction." | 1.30 | Concurrent administration of amrinone with nitric oxide most improves PaO2/FiO2 in acute respiratory and cardiac failure. ( Fujimori, M; Hayashi, M; Yamada, T; Yukioka, H, 1999) |
| " Catecholamine dosage was held constant during the period of the study." | 1.27 | Effect of amrinone in acute severe cardiac failure. ( Frenking, B; Gülker, H; Heuer, H, 1988) |
| "Amrinone (A) has been administered to 10 patients with low postoperative cardiac output as unique inotropic therapy and to 34 patients in severe cardiogenic shock, despite optimal treatment." | 1.27 | New inotropic-vasodilating drugs in acute and chronic heart failure. ( Goenen, MJ, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (55.56) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jentzer, JH | 1 |
| Lejemtel, TH | 1 |
| Sonnenblick, EH | 1 |
| Kirk, ES | 1 |
| Seta, Y | 1 |
| Kanda, T | 1 |
| Yokoyama, T | 1 |
| Kobayashi, I | 1 |
| Suzuki, T | 1 |
| Nagai, R | 1 |
| Yukioka, H | 1 |
| Hayashi, M | 1 |
| Yamada, T | 1 |
| Fujimori, M | 1 |
| Costa, P | 1 |
| Agrò, C | 1 |
| Gulotta, G | 1 |
| Papa, G | 1 |
| Piazza, F | 1 |
| Ronga, F | 1 |
| Sparacia, B | 1 |
| Sansone, A | 1 |
| Burns, P | 1 |
| Ondrejicka, JS | 1 |
| Messner-Pellenc, P | 1 |
| Puech, P | 1 |
| Goldstein, RA | 1 |
| Heuer, H | 1 |
| Frenking, B | 1 |
| Gülker, H | 1 |
| Goenen, MJ | 1 |
2 reviews available for amrinone and Acute Disease
| Article | Year |
|---|---|
[Multicenter study of the hemodynamic action of intravenous amrinone in the treatment of acute congestive cardiac failure].
Topics: Acute Disease; Adult; Aged; Amrinone; France; Heart Failure; Hemodynamics; Humans; Middle Aged; Mult | 1988 |
Inotropic support in patients with left ventricular dysfunction.
Topics: Acute Disease; Amrinone; Catecholamines; Digitalis Glycosides; Heart Failure; Humans | 1987 |
1 trial available for amrinone and Acute Disease
| Article | Year |
|---|---|
[Multicenter study of the hemodynamic action of intravenous amrinone in the treatment of acute congestive cardiac failure].
Topics: Acute Disease; Adult; Aged; Amrinone; France; Heart Failure; Hemodynamics; Humans; Middle Aged; Mult | 1988 |
7 other studies available for amrinone and Acute Disease
| Article | Year |
|---|---|
Beneficial effect of amrinone on myocardial oxygen consumption during acute left ventricular failure in dogs.
Topics: Acute Disease; Aminopyridines; Amrinone; Animals; Blood Circulation; Coronary Circulation; Dogs; Fem | 1981 |
Effect of amrinone on murine viral myocarditis.
Topics: Acute Disease; Amrinone; Animals; Cells, Cultured; Cyclic AMP; Female; Heart; Mice; Mice, Inbred C3H | 1997 |
Concurrent administration of amrinone with nitric oxide most improves PaO2/FiO2 in acute respiratory and cardiac failure.
Topics: Acute Disease; Amrinone; Cardiotonic Agents; Drug Therapy, Combination; Heart Failure; Hemodynamics; | 1999 |
[Efficacy and safety of amrinone in the treatment of heart insufficiency in intensive care].
Topics: Acute Disease; Aged; Aged, 80 and over; Amrinone; Chronic Disease; Critical Care; Female; Heart Fail | 1992 |
Criteria for use of amrinone lactate in hospitalized adult patients.
Topics: Acute Disease; Adult; Amrinone; Clinical Protocols; Heart Failure; Hospitalization; Humans; Middle A | 1990 |
Effect of amrinone in acute severe cardiac failure.
Topics: Acute Disease; Adult; Amrinone; Blood Pressure; Female; Heart Failure; Heart Rate; Humans; Male; Mid | 1988 |
New inotropic-vasodilating drugs in acute and chronic heart failure.
Topics: Acute Disease; Administration, Oral; Amrinone; Cardiotonic Agents; Chronic Disease; Heart Failure; H | 1986 |